These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36620154)
21. Elevated tumor-to-liver standardized uptake value ratio (TLR) from preoperative Wu C; Cui Y; Zhao Y; Chen X; Liao X; Di L; Yin L; Liu M; Wang R Eur J Radiol; 2020 Oct; 131():109218. PubMed ID: 32882538 [TBL] [Abstract][Full Text] [Related]
22. Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714 [TBL] [Abstract][Full Text] [Related]
23. Predictive Value of Metabolic Parameters Derived From Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B Front Immunol; 2021; 12():724464. PubMed ID: 34512653 [TBL] [Abstract][Full Text] [Related]
24. Utility of Early Posttreatment PET/CT Evaluation Using FDG or Reizine E; Chalaye J; Mule S; Regnault H; Perrin C; Calderaro J; Laurent A; Amaddeo G; Kobeiter H; Tacher V; Itti E; Luciani A AJR Am J Roentgenol; 2022 Feb; 218(2):359-369. PubMed ID: 34494448 [No Abstract] [Full Text] [Related]
25. Diagnostic performance and prognostic value of preoperative Chen S; Zhao Y; Tang Q; Wu C; Wang A; Ma L; Zhang X; Chen J; Gao Y; Liao X; Feng N; Fan Y; Zhang J; Li X; Liu M Cancer Imaging; 2022 Nov; 22(1):65. PubMed ID: 36435856 [TBL] [Abstract][Full Text] [Related]
26. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications. Rhee H; Cho ES; Nahm JH; Jang M; Chung YE; Baek SE; Lee S; Kim MJ; Park MS; Han DH; Choi JY; Park YN J Hepatol; 2021 Jan; 74(1):109-121. PubMed ID: 32818570 [TBL] [Abstract][Full Text] [Related]
27. A gadoxetic acid-enhanced MRI-based multivariable model using LI-RADS v2018 and other imaging features for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Liang Y; Xu F; Wang Z; Tan C; Zhang N; Wei X; Jiang X; Wu H Eur J Radiol; 2022 Aug; 153():110356. PubMed ID: 35623312 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysis. Kim K; Kim SJ Clin Imaging; 2021 Nov; 79():251-258. PubMed ID: 34157501 [TBL] [Abstract][Full Text] [Related]
29. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization. Park S; Kim TS; Kang SH; Kim HB; Park JW; Kim SK Medicine (Baltimore); 2018 Sep; 97(37):e12311. PubMed ID: 30212970 [TBL] [Abstract][Full Text] [Related]
30. Dual-Energy CT Deep Learning Radiomics to Predict Macrotrabecular-Massive Hepatocellular Carcinoma. Li M; Fan Y; You H; Li C; Luo M; Zhou J; Li A; Zhang L; Yu X; Deng W; Zhou J; Zhang D; Zhang Z; Chen H; Xiao Y; Huang B; Wang J Radiology; 2023 Aug; 308(2):e230255. PubMed ID: 37606573 [TBL] [Abstract][Full Text] [Related]
31. Corona enhancement combined with microvascular invasion for prognosis prediction of macrotrabecular-massive hepatocellular carcinoma subtype. Yang L; Wang M; Zhu Y; Zhang J; Pan J; Zhao Y; Sun K; Chen F Front Oncol; 2023; 13():1138848. PubMed ID: 36890813 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma. Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589 [TBL] [Abstract][Full Text] [Related]
33. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer. Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680 [TBL] [Abstract][Full Text] [Related]
35. CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma. Feng Z; Li H; Liu Q; Duan J; Zhou W; Yu X; Chen Q; Liu Z; Wang W; Rong P Radiology; 2023 Apr; 307(1):e221291. PubMed ID: 36511807 [TBL] [Abstract][Full Text] [Related]
36. Nomogram for the Preoperative Prediction of the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma. Shan Y; Yu X; Yang Y; Sun J; Wu S; Mao S; Lu C J Hepatocell Carcinoma; 2022; 9():717-728. PubMed ID: 35974953 [TBL] [Abstract][Full Text] [Related]
37. [Value of (18)F-FDG PET-CT imaging to predict epidermal growth factor receptor mutations in patients with lung squamous cell carcinoma]. Zhao CY; Deng XY; Wang HS; Cao GP; Ding JN; Ding CY Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):795-800. PubMed ID: 34289575 [No Abstract] [Full Text] [Related]
38. The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE). Ma W; Jia J; Wang S; Bai W; Yi J; Bai M; Quan Z; Yin Z; Fan D; Wang J; Han G Theranostics; 2014; 4(7):736-44. PubMed ID: 24883123 [TBL] [Abstract][Full Text] [Related]
39. Predictive value of multiple metabolic and heterogeneity parameters of Shi A; Wang J; Wang Y; Guo G; Fan C; Liu J Ann Nucl Med; 2022 Apr; 36(4):393-400. PubMed ID: 35084711 [TBL] [Abstract][Full Text] [Related]
40. Value of [18F]FDG-PET/CT and CA125, serum levels and kinetic parameters, in early detection of ovarian cancer recurrence: Influence of histological subtypes and tumor stages. Palomar Muñoz A; Cordero García JM; Talavera Rubio MDP; García Vicente AM; Pena Pardo FJ; Jiménez Londoño GA; Soriano Castrejón Á; Aranda Aguilar E Medicine (Baltimore); 2018 Apr; 97(17):e0098. PubMed ID: 29702969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]